Original Research
Accepted on 14 Nov 2025
Branched tetrameric lactoferricin peptides modified with diaminopropionic acid exhibit potent antimicrobial and wound-healing activities
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Type at least 3 characters
428 articles
Review
Published on 13 Nov 2025
Myasthenia gravis and community-acquired pneumonia: therapeutic challenges
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695526
- 415 views
Review
Published on 12 Nov 2025
Polyphenolic compounds in combating MDR periodontal pathogens: current research and future directions
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678979
- 357 views
Original Research
Published on 12 Nov 2025
Tigecycline pharmacodynamics in the hollow fiber system of Mycobacterium avium-complex lung disease and the utility of MICs and time-kill studies in drug development
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1682477
- 309 views
Original Research
Published on 10 Nov 2025
A novel drug that reduces pneumococcal toxicity by targeting pneumolysin (PLY): efficacy of the traditional Chinese medicine Radix Paeoniae Alba
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1609457
- 443 views
Systematic Review
Published on 06 Nov 2025
Association between point mutations of macrolide-resistant Mycoplasma pneumoniae and clinical antibiotic treatment efficacy: a meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1682167
- 693 views
Original Research
Accepted on 31 Oct 2025
Efficacy and safety of omadacycline for the treatment of infectious diseases: a real-world, retrospective study of 2587 patients
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
- 319 views
Review
Accepted on 31 Oct 2025
Design and Synthesis of Natural Antibacterial Derivatives for Ocular Tuberculosis: A Comprehensive Review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
- 117 views
Original Research
Published on 29 Oct 2025
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654173
- 1,016 views
Systematic Review
Published on 29 Oct 2025
Factors affecting the effectiveness and safety of colistin in treating drug-resistant gram-negative bacterial infections: a meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1625595
- 700 views
Review
Accepted on 27 Oct 2025
Antiretroviral Therapy and Associated Drug Interactions with Cardiovascular Drugs: A Critical Review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
- 240 views
Original Research
Published on 27 Oct 2025
Comparative in vitro susceptibility of clinical Leishmania isolates to miltefosine and oleylphosphocholine
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1688856
- 891 views
Original Research
Published on 27 Oct 2025
Synthetic bakuchiol derivatives: ester and ether analogs with activity against clinically important bacteria
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1619997
- 672 views
Opinion
Published on 24 Oct 2025
Green-synthesized silver nanoparticle hydrogels for biofilm-infected wounds: Bridging sustainability and clinical translation
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694144
- 873 views
- 1 citation
Original Research
Published on 17 Oct 2025
GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1639673
- 1,879 views
Editorial
Published on 14 Oct 2025
Editorial: Multidrug resistant bacteria: new therapeutic approaches for a challenging problem
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1712353
- 819 views